RxDoctor Payments Data

Pamela Hancock, APRN

Gerontology · Monticello, KYNPI 1285347112

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Vanda Pharmaceuticals Inc. at 28.9% of the total. 2025 is the largest year on record at $117, 7.5 times the $16 reported in 2022. That places this record below the midpoint for gerontology clinicians in KY, where the typical reported total is $349.

$257in general payments, 2019–2025

Across 14 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$74
  • Lilly USA, LLC$62
  • AbbVie$35
  • Agios Pharmaceuticals, Inc.$22
  • Baxter Healthcare$20
  • Bayer$16
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$257 in reported general payments places this provider in the 45th percentile of 84 gerontology providers in Kentucky.

See all gerontology providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,619
Medicare patients
76
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$24,164
EliquisApixaban25$18,973
JardianceEmpagliflozin19$16,728
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$15,468
JanuviaSitagliptin Phosphate18$12,901
LinzessLinaclotide13$7,095
Spiriva HandihalerTiotropium Bromide12$5,951
Albuterol Sulfate HfaAlbuterol Sulfate95$2,295
Ventolin HfaAlbuterol Sulfate18$1,005
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$934
Estradiol15$931
Celecoxib28$732
SynthroidLevothyroxine Sodium15$704
Omeprazole58$644
Atorvastatin Calcium77$617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$14$12,90118 claims
AbbVieLinzess, Synthroid$35$7,79928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 84 gerontology providers in Kentucky.

Other gerontology in Monticello

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →